Nathaniel Dalton (’91) named to iCAD board of directors
iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Nathaniel Dalton (’91) was appointed to its Board of Directors.